ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,487Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 98

$500K Total Retail Price of All Prescriptions

Rank: 28 out of 98

327 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 327 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

9% of this provider’s 327 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 7,251 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 483 434 1 2
LEVOTHYROXINE SODIUM 453 368 2 5
OMEPRAZOLE 431 356 3 6
FUROSEMIDE 374 366 4 4
GABAPENTIN 322 265 5 13
LISINOPRIL 283 250 6 3
CITALOPRAM HBR 219 190 7 10
WARFARIN SODIUM 214 200 8 1
METOPROLOL SUCCINATE 191 165 9 16
METFORMIN HCL 154 150 10 15
HYDROCODONE-ACETAMINOPHEN 152 111 S3 11 39
SERTRALINE HCL 150 144 12 19
METOPROLOL TARTRATE 143 115 13 8
TAMSULOSIN HCL 141 140 14 25
AMLODIPINE BESYLATE 131 131 15 7
MELOXICAM 126 102 16 163
TRIAMTERENE-HCTZ 117 108 17 111
TRAMADOL HCL 114 88 18 26
ATORVASTATIN CALCIUM 97 91 19 20
DIGOXIN 86 86 20 40
LOSARTAN POTASSIUM 80 75 21 34
NABUMETONE 79 51 22 174
CRESTOR 74 73 23 51
TRIAMTERENE-HYDROCHLOROTHIAZID 70 68 24 262
AZITHROMYCIN 68 59 25 104
SPIRONOLACTONE 68 63 25 71
PRAVASTATIN SODIUM 65 46 27 41
LORAZEPAM 64 64 28 205
ESCITALOPRAM OXALATE 62 41 29 60
OXYCODONE-ACETAMINOPHEN 62 24 S2 29 78
TRAZODONE HCL 62 43 29 9
POLYETHYLENE GLYCOL 3350 61 57 32 33
ADVAIR DISKUS 60 47 33 32
GLIPIZIDE 59 57 34 37
LEVOFLOXACIN 57 47 35 63
OXYCONTIN 57 20 S2 35 198
MIRTAZAPINE 56 56 37 11
ATENOLOL 54 54 38 14
ALLOPURINOL 51 51 39 43
POTASSIUM CHLORIDE 51 50 39 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.